DNB Asset Management AS grew its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 164.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 25,813 shares of the company’s stock after buying an additional 16,067 shares during the quarter. DNB Asset Management AS’s holdings in Astera Labs were worth $4,294,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Astera Labs by 11,529.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 38,376 shares of the company’s stock valued at $6,384,000 after buying an additional 38,046 shares during the period. Bank Julius Baer & Co. Ltd Zurich boosted its holdings in shares of Astera Labs by 22.6% in the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,152 shares of the company’s stock valued at $358,000 after buying an additional 397 shares during the period. Allworth Financial LP boosted its holdings in shares of Astera Labs by 3.8% in the fourth quarter. Allworth Financial LP now owns 3,154 shares of the company’s stock valued at $525,000 after buying an additional 116 shares during the period. Freemont Management S.A. boosted its holdings in shares of Astera Labs by 693.6% in the fourth quarter. Freemont Management S.A. now owns 111,900 shares of the company’s stock valued at $18,616,000 after buying an additional 97,800 shares during the period. Finally, Pier 88 Investment Partners LLC boosted its holdings in shares of Astera Labs by 8.7% in the fourth quarter. Pier 88 Investment Partners LLC now owns 3,260 shares of the company’s stock valued at $542,000 after buying an additional 260 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Stock Up 13.3%
Shares of ALAB stock opened at $244.26 on Wednesday. The company’s fifty day simple moving average is $159.81 and its 200-day simple moving average is $157.14. The firm has a market cap of $41.87 billion, a PE ratio of 165.04, a P/E/G ratio of 2.85 and a beta of 3.35. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $262.90.
Insiders Place Their Bets
In other Astera Labs news, CEO Jitendra Mohan sold 139,951 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the sale, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at approximately $786,465,269.28. This represents a 3.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $200.03, for a total transaction of $701,105.15. Following the sale, the director directly owned 63,639 shares in the company, valued at $12,729,709.17. This trade represents a 5.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,290,546 shares of company stock valued at $211,225,088. 12.50% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on ALAB shares. JPMorgan Chase & Co. boosted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Weiss Ratings raised shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Finally, UBS Group started coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average price target of $233.75.
Read Our Latest Stock Report on ALAB
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Further Reading
- Five stocks we like better than Astera Labs
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
